Karyopharm Therapeutics Inc. (KPTI) vs Palatin Technologies, Inc. (PTN)
A side-by-side comparison of Karyopharm Therapeutics Inc. and Palatin Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KPTI
Karyopharm Therapeutics Inc.
$0.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PTN
Palatin Technologies, Inc.
$9.41HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — KPTI vs PTN
growth of $100 · dividends reinvested · last 10yKPTI -99.5% (-41.7%/yr)PTN -98.7% (-35.1%/yr)PTN compounded faster over this window
KPTI PTN
KPTI vs PTN: by the numbers
- •PTN is the larger company ($17M vs $15M market cap).
- •Both run net losses; PTN's is the smaller (-63.54% vs -153.28% net margin).
Metrics side by side
Valuation
| Metric | KPTI | PTN |
|---|---|---|
| P/S ratio | 0.10 | 1.27 |
| P/B ratio | N/A | 2.50 |
Profitability
| Metric | KPTI | PTN |
|---|---|---|
| Gross margin | 95.88% | 99.63% |
| Operating margin | -56.17% | -65.74% |
| Net margin | -153.28% | -63.54% |
| ROE | N/A | -125.30% |
| ROIC | N/A | -125.44% |
Growth (annualized)
| Metric | KPTI | PTN |
|---|---|---|
| Revenue CAGR (5Y) | 7.47% | N/A |
| Total return CAGR (5Y) | -62.18% | -55.41% |
Frequently asked
- How have KPTI and PTN total returns compared?
- Over the past 10 years, KPTI delivered -41.85% and PTN delivered -35.08% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.